These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17663455)

  • 1. Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
    Piggott MA; Ballard CG; Rowan E; Holmes C; McKeith IG; Jaros E; Perry RH; Perry EK
    Synapse; 2007 Nov; 61(11):903-11. PubMed ID: 17663455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
    Duda JE
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.
    Walker Z; Costa DC; Janssen AG; Walker RW; Livingstone G; Katona CL
    Eur J Nucl Med; 1997 Jun; 24(6):609-14. PubMed ID: 9169566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
    McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
    Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.
    Joyce JN; Myers AJ; Gurevich E
    Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).
    Imamura T; Ishii K; Hirono N; Hashimoto M; Tanimukai S; Kazuai H; Hanihara T; Sasaki M; Mori E
    Neuroreport; 1999 Jun; 10(9):1903-7. PubMed ID: 10501530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
    Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH
    Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
    Goldsmith SK; Shapiro RM; Joyce JN
    Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.
    Kramberger MG; Auestad B; Garcia-Ptacek S; Abdelnour C; Olmo JG; Walker Z; Lemstra AW; Londos E; Blanc F; Bonanni L; McKeith I; Winblad B; de Jong FJ; Nobili F; Stefanova E; Petrova M; Falup-Pecurariu C; Rektorova I; Bostantjopoulou S; Biundo R; Weintraub D; Aarsland D;
    J Alzheimers Dis; 2017; 57(3):787-795. PubMed ID: 28304294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies.
    Weisman D; McKeith I
    Semin Neurol; 2007 Feb; 27(1):42-7. PubMed ID: 17226740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.